Type Segment Analysis: Primary (Largest Segment) vs Secondary (Fastest-Growing Segment)

Primary brain tumors accounted for the largest share of 60.82% in 2026 in the brain tumor diagnosis and therapeutics market, reflecting the substantial need for diagnosis and treatment of tumors that originate within the brain and central nervous system. Clinical management of these tumors often requires coordinated diagnostic imaging, pathology assessment, surgical intervention, radiation, and systemic therapies tailored to tumor characteristics. Increasing emphasis on earlier detection, molecular characterization, and individualized treatment strategies is strengthening demand for comprehensive diagnostic and therapeutic solutions for primary tumors.

Secondary brain tumors are experiencing the fastest growth as improvements in cancer detection and treatment are enabling more patients with cancers originating elsewhere in the body to be identified and managed for intracranial metastases. Advances in imaging, systemic oncology, and targeted treatment approaches are supporting more precise identification and management of metastatic disease. Greater attention to multidisciplinary cancer care is also encouraging closer coordination between neurological and broader oncology services, expanding the need for specialized brain metastasis diagnosis and treatment.

End Use Segment Analysis: Oncology Treatment Centers (Largest Segment) vs Hospitals (Fastest-Growing Segment)

Oncology treatment centers held the largest share of 51.41% in 2026 in the brain tumor diagnosis and therapeutics market, supported by their specialized infrastructure for cancer diagnosis, treatment planning, radiation therapy, and ongoing patient management. These centers bring together oncology expertise and specialized equipment needed to manage complex brain tumors, enabling coordinated treatment pathways and follow-up care. Growing demand for specialized cancer services and increasingly sophisticated therapeutic approaches continues to reinforce the role of dedicated oncology treatment facilities.

Hospitals are advancing at the fastest pace as improvements in multidisciplinary care expand the management of brain tumors across broader hospital-based settings. Hospitals can provide integrated access to neurosurgery, emergency services, diagnostic imaging, intensive care, and oncology, making them particularly important for patients requiring complex or urgent intervention. Increasing investment in advanced clinical capabilities and the growing need for coordinated cancer treatment are supporting greater adoption of brain tumor diagnostic and therapeutic solutions within hospital environments.